CHRONIC FATIGUE AND RISK FACTORS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Hạnh Đặng Thị, Thủy Nguyễn Thị Phương, Nga Nguyễn Thị

Main Article Content

Abstract

Objectives: 1. To evaluate the characteristics of chronic fatigue in patients with rheumatoid arthritis. 2. To determine the risk factors of chronic fatigue in these patients. Subjects and method: A cross-sectional descriptive study, including 60 patients diagnosed with rheumatoid arthritis according to ACR-EULAR 2010 criteria at the Musculoskeletal Center - Bach Mai Hospital from August 2024 to March 2025. Results: Chronic fatigue syndrome was found in 78.3% of patients with rheumatoid arthritis. The patients had an average BRAF-MDQ score of 27.82 ± 18.97, of which the most affected were the physical fatigue score of 11.43 ± 7.11 and the cognitive fatigue score of 7.92 ± 5.89. Factors that increased the risk of chronic fatigue symptoms in rheumatoid arthritis patients included: high disease activity, multiple deformed joints due to disease progression leaving joint adhesions and the disease was not well controlled with conventional DMARDs and biological DMARDs. Conclusions: Chronic fatigue syndrome was a very common extra-articular manifestation in patients with rheumatoid arthritis, especially during disease progression and greatly affects the patient's quality of life. Good control of disease progression with a targeted treatment regimen including conventional DMARDs and biological DMARDs will help improve the prognosis and reduce the risk of disability for these patients. 

Article Details

References

1. Hewlett Sarah, Kirwan John, Bode et (2018), "The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries", Rheumatology, 57(2), 300-308.
2. Diniz Leonardo Rios, Balsamo (2017), "Measuring fatigue with multiple instruments in a Brazilian cohort of early rheumatoid arthritis patients", Revista Brasileira de Reumatologia, 57(5), 431-437.
3. Singh Harpreet, Arya (2014), "Assessment of fatigue in rheumatoid arthritis (by functional assessment of chronic illness therapy–fatigue score) and its relation to disease activity and anemia", Journal of Clinical Rheumatology, 87-90.
4. Strand Vibeke, Mease Philip, Burmester (2009), "Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial", Arthritis research therapy, 11, 1-12.
5. Chauffier Karine, Salliot Carine, Berenbaum Francis, et al. (2012), "Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis", Rheumatology, 51(1), 60-68.